TEM241115P55000
- 1.50
- +1.15+328.57%
Tempus AI Newsroom
Ray Dalio's Bridgewater Cuts Stake In Microsoft Stock By 20% – Is Big Tech Losing Its Shine?
SoundHound AI Plunges Despite Reporting Record Quarterly Revenue
Express News | Red Sky Ventures LLC Reports Passive Stake of 10.9% in Tempus AI as of September 30, 2024 - SEC Filing
ARKK's Holdings Ranked by SA Quant Grades
Trending Stocks Today | BTC Digital Surges 419.84%
Express News | Piper Sandler Reiterates Neutral on Tempus AI, Raises Price Target to $70
Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR
Donald Trump Victory Week (Nov 4-8): These Large Cap Stocks Were Biggest Gainers
Tempus Announces Publication Of Its Study, "Actionable Structural Variant Detection Via RNA-NGS And DNA-NGS In Patients With Advanced Non-small Cell Lung Cancer," In Jama Network Open
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Nvidia To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Monday
Tempus AI Price Target Raised to $65.00/Share From $45.00 by Stifel
Tempus AI Analyst Ratings
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
Tempus AI Downgraded to Hold From Buy at Stifel
Tempus AI, Inc.: Valuation Concerns and Growth Uncertainties Justify Hold Rating
Tempus AI, Inc. (TEM) Q3 2024 Earnings Call Transcript Summary
Sony Posts Upbeat Earnings, Joins Tesla, Upstart, Doximity, Fortrea, Axon Enterprise And Other Big Stocks Moving Higher On Friday
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting